Natalia Bobok

Dr. Natalia Bobok


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2025 in Infusion & Chemotherapy
Verified
Journal Article
Open access
PDF file
МLМ.і. Lynnyk
М.і. Lynnyk
VІV.і. Іgnatieva
V.і. Іgnatieva
GGG.L. Gumeniuk
G.L. Gumeniuk
VSV.а. Svyatnenko
V.а. Svyatnenko
NBNatalia Bobok
Natalia Bobok
BACKGROUND. In patients with widespread pulmonary tuberculosis, the disease with pronounced symptoms of intoxication may be due to the disruption of protein metabolism and the function of the hepatobiliary system, and thus, a decrease in the level of amino acids in the liver, protein, substituted for ammonia, indicators of ALT, AST, thymol test. Changing biochemical test results to confirm the presence of hepatotoxic, cholestatic or mixed side effects of antimycobacterial drugs. Their influx into the development of osteoporosis without surviving, behind the blame of lonely work twenty years ago. In connection with this, diagnosis and treatment of the dynamics of disruption of mineral metabolism of bone tissue in patients with drugresistant tuberculosis based on computed tomography (CT) data of the chest organs are relevant. OBJECTIVE. To monitor the dynamics of mineral thickness of bone tissue of the spine and the development of osteoporosis in patients with drug-resistant tuberculosis according to CT of the chest organs and demonstrate on clinical butts. MATERIALS AND METHODS. Densitometry was carried out using the K-Pacs program. The results were compared with the results of diagnosing osteoporosis based on the standardized 3D QCT program. 38 patients with drug-resistant pulmonary tuberculosis were analyzed in the dynamics of CT of the chest organs, in which monitoring of the structure (Th12, L1-L2) of the ridges was carried out for the lowest values of densitometric indicators (average, minimum and maximum bone mineral density) on axial CT sections. Control examination of the bone mineral density was carried out 1 time after the cob. RESULTS. With post-operative release, 39.5 % of patients had a decrease in densitometric indicators of the vertebrae (osteopenia and osteoporosis). During the control fasting after 1 year of the cob, 92.1 % of patients experienced a decrease in densitometric readings, which indicates a decrease in spine metabolism. CONCLUSIONS. The use of CT data of the chest organs for diagnosing disorders of mineral metabolism in bone tissue of the spine in patients with pulmonary tuberculosis is an accessible and informative method.

22 May 2025 in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Verified
Journal Article
Open access
PDF file
NBNatalia Bobok
Natalia Bobok
Social media shapes aesthetic trends in modern society significantly. Changes in requirements of aesthetic and plastic surgery based on these social trends have been repeatedly demonstrated. Social trends shape not only the requirements for appearance but also affect the pharmaceutical choice of the population. A clear example is the growing use of weight loss medicines. Glucagon-like peptide-1 (GLP-1) receptor agonists are widely prescribed for the treatment of type 2 diabetes and obesity, but they also affect a variety of physiological processes. Deep understanding of the effects of GLP-1 agonists on glucose metabolism, insulin secretion and gastrointestinal function is essential for optimal therapy selection and justification for using these medicines for weight management in patients without concomitant diabetes. An important feature of GLP-1 drugs is their ability to modulate appetite through effect on the hypothalamus, which makes them promising for the treatment of obesity. Studies show that these drugs affect not only carbohydrate metabolism but also the cardiovascular system and kidney function. However, their prolonged and unreasonable use may be accompanied by undesirable effects. Additional research and observations are needed on the long-term effects of GLP-1 on carbohydrate metabolism, weight management, gastrointestinal, liver, kidney function, and metabolic status of patients. Studying the mechanisms of action of of this group of agents will allow more accurately predict the individual effectiveness and risks of therapy. Accordingly, physicians need to understand the pharmacological effects of these drugs, as they will increasingly encounter patients who want to use or already take GLP-1 receptor agonists. Despite the fact that the media widely cover this issue, a comprehensive scientific description of the pharmacological effects, indications, prescribing features and potential consequences of GLP-1 agonists are relevant.

21 July 2026 in npj Metabolic Health and Disease
Verified
Journal Article
Open access
PDF file
NBNatalia Bobok
Natalia Bobok
The liver is the principal organ responsible for maintaining systemic glucose homeostasis through the integrated regulation of gluconeogenesis, glycogenolysis, glycogenesis, and glycolysis. As fasting progresses and hepatic glycogen stores decline, gluconeogenesis becomes the dominant source of endogenous glucose production required to preserve euglycemia. This review summarizes the regulation of gluconeogenesis and discusses the clinical manifestations, diagnostic implications, and therapeutic relevance of gluconeogenic dysfunction across diverse disease states.

17 December 2025 in Problems of ageing and longevity (Ukraine)
Verified
Journal Article
Closed access
NBNatalia Bobok
Natalia Bobok
OHOleksandr Halushko
Oleksandr Halushko
In recent years, a new group of drugs has emerged among potential anti-aging agents – glucagon-like peptide-1 (GLP-1) receptor agonists. However, there are not enough published studies yet that demonstrate the role of GLP-1 agonists in the treatment of age-related diseases and aging. The aim: Based on the analysis of scientific literature, to establish the role and prospects for the use of GLP-1 receptor agonists for the prevention of aging and the treatment of age-related diseases. Material and methods. To achieve this goal, a search and analysis of full-text articles was conducted using the PubMed, Web of Science and Scopus databases over the past 25 years (from September 2000 to October 2025). Results: GLP-1 agonists act by activating the GLP-1 receptor. They mimic the actions of the endogenous hormone GLP-1, which is secreted by the intestine after a meal. They slow gastric emptying, inhibit glucagon release, and stimulate insulin secretion, thereby reducing hyperglycemia in people with type 2 diabetes. They also reduce food intake and body weight. The use of GLP-1 agonists has been shown to be effective in a number of pathological conditions: atherosclerosis, cardiovascular disease, asthma, neurodegenerative diseases, nonalcoholic steatohepatitis, chronic kidney disease, etc.

1 September 2025
Verified
Journal Article
Open access
PDF file
NBNatalia Bobok
Natalia Bobok
OHOleksandr Halushko
Oleksandr Halushko
Platelet-rich plasma (PRP) has been frequently mentioned as a potential anti-aging agent in recent years. However, there is still a lack of published scientific data demonstrating the potential of PRP for skin rejuvenation, scar treatment, and hair loss. The aim: Based on the analysis of the scientific literature, to establish the possibilities and prospects for the use of PRP for the treatment of age-related and acquired skin changes. Material and methods. To achieve this goal, a search and analysis of full-text articles was conducted using the PubMed, Web of Science, and Scopus databases over the past 20 years (from July 2005 to July 2025). Results. PRP has the potential to deliver high concentrations of growth factors to target tissues, modulate angiogenesis and cell chemotaxis, and mediate macrophage transformation to promote wound healing. PRP also causes soft tissue enlargement, activation of fibroblasts and collagen deposition, formation of new blood vessels and adipose tissue, can increase the length of dermal epidermal junctions, improve skin elasticity and reduce tissue edema, thereby achieving the purpose of tissue regeneration. At the same time, there are a number of biological, technical and social factors that limit the use of PRP. Conclusions. Due to its unique effects, PRP may be a promising anti-aging medicine in dermatology. However, there is a need for further prospective randomized controlled trials with large samples.

23 March 2025 in Infusion & Chemotherapy
Verified
Journal Article
Open access
PDF file
ODO.B. Dynnyk
O.B. Dynnyk
SMS.YE. Mostovyi
S.YE. Mostovyi
NBNatalia Bobok
Natalia Bobok
VMV.YE. Medvediev
V.YE. Medvediev
BACKGROUND. Coronavirus disease 2019 (COVID-19) and coronary heart disease (CHD) are pandemics, their synergy significantly affects population morbidity and mortality. Growing evidence suggests that COVID-19 may worsen the state of the CHD precisely by aggravating endothelial dysfunction. In this article, we review the mechanisms of endothelial injury and the role of different therapeutic strategies in protecting the endothelium and improving prognosis in the treatment of CHD patients infected with SARS-CoV-2. OBJECTIVE. The role of different therapeutic agents, as well as lifestyle modifications (exercise and diet) in patients with CHD in combination with COVID-19, was determined to improve endothelial function, prognosis and survival of this cohort of patients. RESULTS. Endothelial protection is an important therapeutic strategy in the treatment of patients with CHD and COVID-19. The use of statins, angiotensin-converting enzyme inhibitors, sartans, new anticoagulants, L-arginine, sulodexide, citicoline, resveratrol, targeted foods, and walking can help reduce endothelial dysfunction, the risk of complications and improve the prognosis of these lesions. A comprehensive approach to treatment, including drug therapy and lifestyle modification, is the key to effective management of the endothelium condition in the case of CHD and COVID-19.